Kevin Patrick Moran - 18 Feb 2025 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP, CFO & Treasurer
Signature: /s/ Kevin Patrick Moran
Issuer symbol: VNDA
Transactions as of: 18 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 20 Feb 2025, 19:44:48 UTC
Previous filing: 29 Jul 2024
Next filing: 24 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Award	$0	+125,000	+55%	$0.000000	353,763	18 Feb 2025	Direct	F1
holding	VNDA	Common Stock						635	18 Feb 2025	By Wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2026, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Content

Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2026, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.